Drugs for Neglected Diseases Initiative   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Geneva Switzerland (1999)

Organization Overview

First Clinical Trial
1999
NCT02386358
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Drugs for Neglected Diseases | Drugs for neglected Diseases initiative | Drugs for Neglected Diseases initiative